Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EntreMed completes phase I trial with reformulated Panzem

April 29, 2004

Allergan to withdraw PEP-005 INDs, resubmission planned

April 29, 2004

Cellular Genomics patent covers new protein kinase modulators

April 29, 2004

Two novel series of CDK inhibitors presented by Schering-Plough and Pharmacopeia

April 29, 2004

NF-kappaB inhibitor DHMEQ as treatment option for advanced urological cancer

April 29, 2004

Novel proteasome inhibitor ER807446 demonstrates antitumor activity especially against large tumors

April 29, 2004

ViRexx Medical receives grant to fund phase I trial of Occlusin

April 28, 2004

Phase III trial of Tarceva in NSCLC meets endpoints

April 28, 2004

Genmab licenses GT43 cancer target from Ganymed

April 28, 2004

CV Therapeutics describes adenosine A3 agonists for cancer and neutropenia therapy

April 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...